Where does DNA Script SAS rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), DNA Script SAS ranks #31,424 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does DNA Script SAS hold?

DNA Script SAS holds 8 US utility patents granted between 2021 and 2025, spanning 8 technology areas.

What is DNA Script SAS's Innovation Score?

DNA Script SAS has an Innovation Score of 44.9 out of 100 (top 24% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is DNA Script SAS's patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for DNA Script SAS.

What does claim depth mean for DNA Script SAS's patents?

DNA Script SAS's patents average 12.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the DNA Script SAS patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

DNA Script SAS

Q: What technology areas does DNA Script SAS focus on?

DNA Script SAS's top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 4 patents, ranking #2,122 of 4,144 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

USPTO PatentsView assignee record - 8 granted patents across 8 technology areas, recorded in grant years 2021–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, DNA ranks #31,424 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 8 technology areas.

#31,424
of 49,997 US assignees by volume: Top 24%
by Innovation Score (44.9/100): 12.1
avg claims per patent

USPTO PatentsView assignee plate

Corpus R31424 · Foreign Corporation #31,424 · 8 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 8 grants
MID-PACK #31,424/49,997
PHOTO-FINISH DJO Global Switzerla…
CPC-NARROW C12N · 8 areas
INNOV-PAR 44.9/100
CLAIMS-RICH 12.1 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2021–2025 · 5y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: DJO Global Switzerland SÀRL (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How DNA’s 44.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 7.6 pts (17%) Velocity 20.0 pts (45%) Breadth 10.0 pts (22%) Claim depth 7.3 pts (16%)

Qualcomm Incorporated · highest

85
DNA Script SAS · this assignee

45
3D Lighting… · lowest

7

What this shows DNA's Innovation Score is 44.9/100 (top 24% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for DNA?

Each dot is one of DNA’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). DNA’s own 12.1 claims/patent is at or below the 14.3 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

DNA vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where DNA's grants concentrate

DNA Script SAS is a focused PatentsView assignee: 8 CPC subclasses with 50% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2022 (3 grants) versus a trough of 1 in 2021. By volume, DNA sits between DJO Global Switzerland SÀRL and Dong Yang Piston Co., Ltd..

DNA's three-year grant acceleration

DNA Script SAS shows 6 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

DJO Global Switze…

8
DLX Enterprises

8
Dm3d Technology

8
DMC

8
DNT Scientific Re…

8
Dolphin Fluidics…

8
Dominion Engineer…

8
Dong Yang Piston

8
DNA Script SAS ◀

8

What this shows DNA holds 8 patents at rank #31,397, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near DNA

By rank, the assignees closest to #31,397 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in DNA's primary technology class.

DNA's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

45 Top 24% higher than 76% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2021–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table

DNA Script SAS patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2021	1	12.5%
2022	3	37.5%
2023	1	12.5%
2024	2	25.0%
2025partial year	1	12.5%

Which technologies does DNA Script SAS patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 4

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 4

C12Y - Enzymes 2

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 2

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 2

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 2

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 2

C40B - Combinatorial CHEMISTRY; Libraries, e.g. Chemical Libraries 2

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

DNA Script SAS's patent record in context - here's where to go next.

DNA Script SAS's lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 50% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #31,424 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare DNA Script SAS against DJO Global Switzerland SÀRL, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 44.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.